Neogen [NEOG] vs Revvity [RVTY] Detailed Stock Comparison

Neogen Corporation

NASDAQ
Loading...

Revvity Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Neogen Corporation wins in 6 metrics, Revvity Inc. wins in 13 metrics, with 0 ties. Revvity Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Neogen Corporation Revvity Inc. Better
P/E Ratio (TTM) 865.00 45.77 Revvity Inc.
Price-to-Book Ratio 0.98 1.46 Neogen Corporation
Debt-to-Equity Ratio 37.82 46.87 Neogen Corporation
PEG Ratio 14.79 3.92 Revvity Inc.
EV/EBITDA 33.05 15.48 Revvity Inc.
Profit Margin (TTM) -69.94% 8.45% Revvity Inc.
Operating Margin (TTM) -1.56% 20.07% Revvity Inc.
EBITDA Margin (TTM) N/A 20.07% N/A
Return on Equity -25.57% 3.22% Revvity Inc.
Return on Assets (TTM) -0.61% 2.22% Revvity Inc.
Free Cash Flow (TTM) $-46.35M $509.41M Revvity Inc.
Dividend Yield N/A 0.25% N/A
1-Year Return 53.07% 15.63% Neogen Corporation
Price-to-Sales Ratio (TTM) 2.36 3.69 Neogen Corporation
Enterprise Value $2.69B $13.02B Revvity Inc.
EV/Revenue Ratio 3.09 4.56 Neogen Corporation
Gross Profit Margin (TTM) 46.88% 54.62% Revvity Inc.
Revenue per Share (TTM) $4 $25 Revvity Inc.
Earnings per Share (Diluted) $-2.80 $2.06 Revvity Inc.
Beta (Stock Volatility) 1.97 1.13 Revvity Inc.
Short % of Float 6.18% 11.04% Neogen Corporation

Neogen Corporation vs Revvity Inc. Stock Performance Analysis

Loading Price Chart...

NEOG
RVTY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Neogen Corporation0.69%-4.27%-3.74%-21.52%47.80%25.00%
Revvity Inc.0.68%3.70%16.07%5.04%-2.26%2.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Neogen Corporation53.07%-51.54%-80.17%-53.16%-15.62%296.90%
Revvity Inc.15.63%-9.26%-24.76%91.55%296.02%399.05%

Performance & Financial Health Analysis: Neogen Corporation vs Revvity Inc.

MetricNEOGRVTY
Market Information
Market Cap i$2.04B$9.74B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i3,110,790860,236
90 Day Avg. Volume i2,601,313959,002
Last Close$8.81$101.07
52 Week Range$4.53 - $11.43$81.22 - $118.30
% from 52W High-22.92%-14.56%
All-Time High$48.85 (Apr 26, 2021)$203.16 (Dec 27, 2021)
% from All-Time High-81.97%-50.25%
Growth Metrics
Quarterly Revenue Growth-0.04%0.06%
Quarterly Earnings Growth-0.04%0.04%
Financial Health
Profit Margin (TTM) i-0.70%0.08%
Operating Margin (TTM) i-0.02%0.20%
Return on Equity (TTM) i-0.26%0.03%
Debt to Equity (MRQ) i37.8246.87
Cash & Liquidity
Book Value per Share (MRQ)$9.66$64.57
Cash per Share (MRQ)$0.74$8.23
Operating Cash Flow (TTM) i$69.44M$582.93M
Levered Free Cash Flow (TTM) i$19.47M$523.28M
Dividends
Last 12-Month Dividend Yield iN/A0.25%
Last 12-Month Dividend iN/A$0.28

Valuation & Enterprise Metrics Analysis: Neogen Corporation vs Revvity Inc.

MetricNEOG (Apr 24, 2026)RVTY (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i865.0045.77
Forward P/E i32.1115.70
PEG Ratio i14.793.92
Price to Sales (TTM) i2.363.69
Price to Book (MRQ) i0.981.46
Market Capitalization
Market Capitalization i$2.04B$9.74B
Enterprise Value i$2.69B$13.02B
Enterprise Value Metrics
Enterprise to Revenue i3.094.56
Enterprise to EBITDA i33.0515.48
Risk & Other Metrics
Beta i1.971.13
Book Value per Share (MRQ) i$9.66$64.57

Financial Statements Comparison: Neogen Corporation vs Revvity Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNEOG (2025)RVTY (2025)
Revenue/Sales i894.66M2.86B
Cost of Goods Sold i473.29M1.29B
COGS % of Revenue i52.9%45.2%
Gross Profit i421.38M1.56B
Gross Margin i47.1%54.8%
Research & Development i21.09M215.84M
Operating Income (EBIT) i-1.68M356.64M
Operating Margin i-0.2%12.5%
EBITDA i123.51M792.21M
EBITDA Margin i13.8%27.7%
Pre-Tax Income i-1.13B268.28M
Pre-Tax Income % of Revenue i-126.7%9.4%
Income Tax i-41.07M28.39M
Income Tax % of Revenue i-4.6%1.0%
Net Income (Profit) i-1.09B241.20M
Profit Margin i-122.1%8.4%

Balance Sheet & Liquidity Metrics

MetricNEOG (2025)RVTY (2025)
Cash & Equivalents i129.00M919.86M
Total Current Assets i576.94M2.24B
Total Current Assets % of Revenue i64.5%78.4%
Total Current Liabilities i174.01M1.33B
Total Current Liabilities % of Revenue i19.4%46.6%
Long-Term Debt i874.81M2.78B
Long-Term Debt % of Revenue i97.8%97.3%
Total Shareholders Equity i2.07B7.25B
Retained Earnings i-536.42M6.05B
Retained Earnings % of Revenue i-60.0%212.0%
Property, Plant & Equipment i17.15M165.44M

Cash Flow Statement Comparison

MetricNEOG (2025)RVTY (2025)
Operating Cash Flow i-1.01B586.69M
Operating Cash Flow % of Revenue i-113.0%20.5%
Capital Expenditures i-99.52MN/A
Free Cash Flow i-46.35M509.41M
FCF Margin i-5.2%17.8%
Debt Repayment i-550.32M-521,000
Common Stock Repurchase iN/A-820.82M

Short Interest & Institutional Ownership Analysis

MetricNEOGRVTY
Shares Short i10.07M8.24M
Short Ratio i4.097.79
Short % of Float i6.18%11.04%
Shares Outstanding i217.67M112.28M
Float Shares i216.51M102.65M
% Held by Insiders i0.94%0.34%
% Held by Institutions i106.92%103.68%
% Held by Public i-7.86%-4.02%

Dividend Analysis & Yield Comparison: Neogen Corporation vs Revvity Inc.

MetricNEOGRVTY
Last 12-Month Dividend iN/A$0.28
Last 12-Month Dividend Yield iN/A0.25%
3-Year Avg Annual Dividend iN/A$0.28
3-Year Avg Dividend Yield iN/A0.06%
3-Year Total Dividends iN/A$0.84
Ex-Dividend DateN/AJan 16, 2026